Back to search

Article

Site-Specific Immobilization of Antibodies as a Platform Approach to Enable the Targeted Capture and Effective Removal of “Problematic” Host Cell Proteins (HCPs) from Complex Bioprocess Streams, Even at Sub-ppm Levels: Chinese Hamster Ovary (CHO) Phospholipase B-Like 2 (PLBL2)

2025-06-12

Abstract excerpt

Removal of host cell proteins (HCPs) during biotherapeutics manufacturing is vital for ensuring patient safety and biotherapeutic stability and supply. Yet, this goal remains exceptionally challenging for some HCPs. For example, phospholipase B-like 2 (PLBL2) from Chinese hamster ovary (CHO) cells (the workhorse for therapeutic protein production) plagues engineers by evading typical purification strategies. New t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e5ad7cb-8fa0-577f-9992-483d3948c934
DOI
10.22541/au.173372831.15992718/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Site-Specific Immobilization of Antibodies as a Platform Approach to Enable the Targeted Capture and Effective Removal of “Problematic” Host Cell Proteins (HCPs) from Complex Bioprocess Streams, Even at Sub-ppm Levels: Chinese Hamster Ovary (CHO) Phospholipase B-Like 2 (PLBL2)DOI 10.22541/au.173372831.15992718/v2
Select a neighboring publication to make it the new centre.